4//SEC Filing
COOPER GLENN L MD 4
Accession 0001140361-18-024447
CIK 0000730272other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:43 PM ET
Size
7.2 KB
Accession
0001140361-18-024447
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
COOPER GLENN L MD
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-05-16+3,304→ 3,304 totalExercise: $42.07From: 2019-05-16Exp: 2028-05-16→ Common Stock (3,304 underlying) - Award
Common Stock
2018-05-16+1,486→ 39,786 total
Footnotes (2)
- [F1]Dr. Cooper was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Award vests in full one year from grant date on May 16, 2019.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeother
Related Parties
1- filerCIK 0001046351
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:43 PM ET
- Size
- 7.2 KB